Ads
related to: intrinsic asthma treatment drugs medications list template free printable- Asthma Self-Assessment
Take The Quiz To Better Understand
Your Asthma & Treatment Options.
- Access FAQ
View Frequently Asked Questions
About Asthma & This Treatment.
- Sign Up To Save
You May Pay As Little As $0 On This
Asthma Treatment If Eligible.
- Get Prescription
See If You're Eligible For This
Asthma Inhaler Option.
- Asthma Self-Assessment
Search results
Results From The WOW.Com Content Network
An anti-asthmatic agent, also known as an anti-asthma drug, refers to a drug that can aid in airway smooth muscle dilation to allow normal breathing during an asthma attack or reduce inflammation on the airway to decrease airway resistance for asthmatic patients, or both. The goal of asthmatic agents is to reduce asthma exacerbation frequencies ...
Treatment for exercise-induced asthma is similar to other forms of the condition; the main difference is that you will take your medication before exercising as a preventive measure.
Printable version; In other projects ... These drugs are used for the treatment of asthma. They may be useful either in the treatment or prevention of asthma attacks ...
Aspirin-exacerbated respiratory disease (AERD), also called NSAID-exacerbated respiratory disease (N-ERD) or historically aspirin-induced asthma and Samter's Triad, is a long-term disease defined by three simultaneous symptoms: asthma, chronic rhinosinusitis with nasal polyps, and intolerance of aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs).
Overuse of β 2 agonists and asthma treatment without proper inhaled corticosteroid use has been associated with an increased risk of asthma exacerbations and asthma-related hospitalizations. [8] The excipients, in particular sulfite , could contribute to the adverse effects.
In the United States. it was approved by the Food and Drug Administration (FDA) under the trade name Arcapta Neohaler on July 1, 2011) [12] olodaterol: approved in some European countries and Russia, and by the U.S. Food and Drug Administration (FDA) on July 31, 2014, under Striverdi Respimat [13]